Doravirine/lamivudine/tenofovir Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with doravirine/lamivudine/tenofovir
G
- G-1 (acetaminophen / butalbital / caffeine)
- gallium nitrate
- Gamimune (immune globulin intravenous)
- Gamimune N 10% (immune globulin intravenous)
- Gamimune N 5% (immune globulin intravenous)
- Gammagard Liquid (immune globulin intravenous and subcutaneous)
- Gammagard S/D (immune globulin intravenous)
- Gammaked (immune globulin intravenous and subcutaneous)
- Gammaplex (immune globulin intravenous)
- Gammar IV (immune globulin intravenous)
- Gammar-P I.V. (immune globulin intravenous)
- Gamulin Rh (rho (d) immune globulin)
- Gamunex-C (immune globulin intravenous and subcutaneous)
- ganciclovir
- Ganite (gallium nitrate)
- Garamycin (gentamicin)
- Gastrografin (diatrizoate)
- Gavreto (pralsetinib)
- Gengraf (cyclosporine)
- Genotropin (somatropin)
- Genpril (ibuprofen)
- gentamicin
- Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)
- Geone (acetaminophen / butalbital / caffeine)
- Giazo (balsalazide)
- gilteritinib
- Givlaari (givosiran)
- givosiran
- glasdegib
- Gleevec (imatinib)
- glipizide / metformin
- Glucophage (metformin)
- Glucophage XR (metformin)
- Glucovance (glyburide / metformin)
- Glumetza (metformin)
- glyburide / metformin
- glycerol phenylbutyrate
- goldenseal
- grepafloxacin
- Grifulvin V (griseofulvin)
- Gris-PEG (griseofulvin)
- Grisactin 250 (griseofulvin)
- Grisactin 500 (griseofulvin)
- Grisactin Ultra (griseofulvin)
- Griseofulicin (griseofulvin)
- Griseofulvic (griseofulvin)
- griseofulvin
More about doravirine / lamivudine / tenofovir
- doravirine/lamivudine/tenofovir consumer information
- Check interactions
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.